Steffen Schaffer

USPTO Granted Patents = 36 (Patent Applications = 20)

CIPO Patents = 6 (Patent Applications = 4)

EPO Patents = 27 (Patent Applications = 63)

Average Co-Inventor Count = 5.0

ph-index = 9

Forward Citations = 177(Granted Patents)

Company Filing History:

Evonik Operations Gmbh

Years Active: 2013-2024

Loading Chart...

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11993803 - Mixture composition comprising glucolipids (2024-05-28),

2. 11685905 - Rhamnolipid-producing cell having reduced glucose dehydrogenase activity (2023-06-27),

3. 11236372 - Lipid production (2022-02-01),

4. 11124813 - N-acetyl homoserine (2021-09-21),

5. 11034938 - Microorganism expressing mutant AlkB enzyme and use to prepare omega-hydroxy carboxylic acid and/or ester (2021-06-15),

6. 10913960 - Biotechnological production of omega-functionalised carboxylic acids and esters thereof (2021-02-09),

7. 10745721 - Process for reacting a carboxylic acid ester (2020-08-18),

8. 10494654 - Production of fatty acids esters (2019-12-03),

9. 10292924 - Mixture composition comprising rhamnolipids (2019-05-21),

10. 10174353 - Methods of producing rhamnolipids (2019-01-08),

11. 10174349 - Recombinant cell producing 2-hydroxyisobutyric acid (2019-01-08),

12. 9944959 - Production of fatty acids esters (2018-04-17),

13. 9765370 - Method for aerobically producing alanine or a compound produced using alanine (2017-09-19),

14. 9725746 - Producing amines and diamines from a carboxylic acid or dicarboxylic acid or a monoester thereof (2017-08-08),

15. 9719117 - Production of omega-amino fatty acids (2017-08-01),

Title: Steffen Schaffer: Pioneering Innovator from Herten

Introduction:

Steffen Schaffer, a distinguished inventor from Herten, Germany, has carved a remarkable path in the realm of technology with his relentless pursuit of innovation. With a stellar track record of 36 patents to his name, Schaffer's contributions have left an indelible mark on the field of inventors.

Latest Patents:

1. Mixture composition comprising glucolipids: Schaffer's latest patent focuses on a mixture composition comprising glucolipids, revolutionizing the production of formulations in the industry.

2. Rhamnolipid-producing cell with reduced glucose dehydrogenase activity: Another groundbreaking invention by Schaffer involves genetically modified cells producing rhamnolipids with decreased glucose dehydrogenase activity, opening new avenues in the realm of biotechnology.

Career Highlights:

Schaffer's innovative prowess has led him to work with prestigious companies such as Evonik Degussa GmbH and Evonik Operations GmbH. His dedication to pushing the boundaries of technology has not only elevated his career but has also significantly impacted the companies he has been a part of.

Collaborations:

Throughout his illustrious career, Schaffer has collaborated with esteemed professionals in the industry, including Mirja Wessel and Thomas Haas. These collaborations have not only enriched his work but have also fostered a culture of innovation and excellence in the teams he has been a part of.

Conclusion:

Steffen Schaffer's legacy as an inventor is characterized by his unwavering commitment to innovation and excellence. His exceptional contributions continue to inspire future generations to reach new heights in the realm of technology and beyond, solidifying his position as a prominent figure in the world of inventors.

This text is generated by artificial intelligence and may not be accurate.